Saratov JOURNAL of Medical and Scientific Research

Efficiency analysis of laser magnetic stimulation of an eye drainage system in the treatment of patients with different stages of primary open angle glaucoma based on developments of functional indicators and biochemistry factors

Year: 2017, volume 13 Issue: №2 Pages: 406-411
Heading: Ophtalmology Article type: Original article
Authors: Filatova V.S., Kamenskikh T.G., Zaharova N.B.
Organization: Saratov State Medical University
Summary:

The purpose of study is to develop efficiency analysis of laser magnetic stimulation of an eye drainage system in the treatment of patients with primary open angle glaucoma (POAG). Material and Methods. The study included 197 patients with established diagnosis of POAG. The first group included 104 patients treated with drug treatment and laser magnetic stimulation of the drainage system of the eye using the «AMO-ATOS-ICL». The second group included 93 patients who received only drug therapy. Patient underwent visometry, oftalmobiomicroscopy, threshold perimetry electrophysiological study, the study of intraocular blood flow, level of VEGF and MCP-1. Results. A comparative analysis showed that the use of laser magnetic stimulation eye's drainage system in the treatment of patients with different stages of POAG to an activation of intraocular blood flow, but it was more significant in patients of the main group who were diagnosed with I and II stages of POAG. The decrease in intraocular blood flow resulted in ischemia while the level of VEGF increased. Conclusion. Analysis of clinical, electrophysiological and hemodynamic parameters in treatment of patients with POAG before and after laser magnetic stimulation improved of the state of the visual system in comparison with those in control group.

Keywords: MCP-1, VEGF

Bibliography:
1. Kamenskikh TG, Raygorodskiy YuM, Veselova EV, et al. Comparative analysis of the results of application of various magnetotherapeutic techniques in the treatment of patients with primary open-angle glaucoma. RMJ Clinical Ophthalmology 2011; (4): 158
2. Quigley Н. Neuronal death in glaucoma. Prog Retin Eye Res 1999; (18): 39-57
3. Chiou-Feng Lin, Shu-Chen Chiu, Yu-Ling Hsiao, et al. Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1. J Immunol 2005; 174 (1): 395-403
4. Viedt C, Dechend R, Fei J, et al. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-кВ and activating protein-1. J Am Soc Nephrol 2002; (13): 15-34
5. Tikhonovich MV, loleva MV. The role of endothelial vascular growth factor in retinal physiology. Journal of the Orenburg State University 2015; (12): 244-249
6. Egorov ЕА, Kamenskikh TG, Raygorodsky YuM, et al. Results of transcranial application of low-intensity magnetic laser therapy in primary open-angle glaucoma patients. Physiotherapy Balneology and Rehabilitation 2013; (5): 15-18
7. Glaucoma. National guide. Edited by Egorov EA. Moscow: GEOTAR, 2013; 824 p.
8. LouissaintA, et al. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 2002; 34 (6): 945-960
9. Nishijima K, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171 (1): 53-67
10. Ruiz de Almodovar C, et al. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009; 89 (2): 607-648
11. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, et al. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27: 2596-2605
12. Eugenin EA, D'Aversa TG, Lopez L, et al. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. Berman JWJ Neurochem 2003; 85 (5): 1299-311
13. Lopatinskaya NR. Remote thermography and analysis of potential reactions in complex assessment of the state of the vision organ in primary open angle glaucoma: PhD diss. Saratov, 2012; 132 p.
14. Dubinina YA. Integrated assessment system state of the disk of the visual nerve in patients with primary open angle glaucoma: PhD diss. Saratov, 2011; 167 p.
15. Abdulaeva EA. Pathogenetic treatment of central involutionary chorioretinal dystrophy: PhD abstract. Ufa, 2002; 21 p.
16. Basinskiy SN, Krasnogorskaya VN, Shtilerman AL, et al. Laser phoresis in the treatment of partial optic atrophy. In: New laser technology in ophthalmology. Kaluga, 2002; 66-67 p.
17. Veselova EV Electrostimulation with biological feedback and magnetic sympathetic correction in the treatment of patients with primary open-angle glaucoma: PhD diss. Saratov, 2011; 127 p.
18. Bessonov АА, Timohina NG, Neskubin NG, et al. Experience in the use of complex treatment of senile macular degeneration. Kybanskij Nauchnyj Medicinskij Vestik 2014; 1 (143): 23-28.

AttachmentSize
2017_02-1_406-411.pdf1.01 MB

No votes yet